Location History:
- Nanjing, CN (2019)
- Jiangsu, CN (2021)
Company Filing History:
1 out of 159 
1 out of 34 Years Active: 2019-2021
Title: Innovations by Xiaojin Zhang: A Pioneer in Pharmaceutical Chemistry
Introduction: Xiaojin Zhang, an accomplished inventor hailing from Jiangsu, China, has established himself in the field of pharmaceutical chemistry. With a remarkable record of two patents, Zhang's innovative contributions focus on enhancing medical treatments through effective pharmaceutical compounds.
Latest Patents: Xiaojin Zhang's latest patents are focused on cutting-edge prolyl hydroxylase inhibitors and compounds showing promising anti-inflammatory properties. One of his significant innovations is an alkynyl pyridine prolyl hydroxylase inhibitor which can enhance the generation and secretion of erythropoietin. This compound has shown potential for treating various types of anemia, such as chronic kidney disease anemia and ischemic diseases like ischemic strokes. Another notable patent revolves around 1-sulfonamido-4-aryloxy compounds, which target inflammation-related diseases. Preliminary tests established that these compounds interfere effectively with the binding of Nrf2 by Keap1, potentially providing avenues for treating conditions such as chronic obstructive pulmonary disease, Alzheimer's, and diabetes.
Career Highlights: Zhang has made significant strides in his career, contributing his expertise to major organizations such as Jiangsu Hengrui Medicine Company Ltd. and China Pharmaceutical University. His work in these esteemed institutions underscores his commitment to advancing pharmaceutical research and development.
Collaborations: Throughout his career, Xiaojin Zhang has collaborated with notable coworkers including Qidong You and Haopeng Sun. These partnerships have allowed for a thriving exchange of ideas and innovations within the realm of pharmaceutical sciences.
Conclusion: Xiaojin Zhang's innovative journey in pharmaceutical chemistry illustrates his dedication to improving health care outcomes through novel inventions. With impactful patents addressing critical medical issues, he remains a prominent figure for future developments in therapeutic solutions.